Resolved: Issue with Submitting Pharmacy Claims (For Some Preferred Brand Name Drugs)

The NCTracks technical team has resolved the issue that caused pharmacy claims for some preferred brand name drugs to deny when DAW 1 or 8 was submitted. Pharmacies may now resubmit their claims.

As reminder, brand preferred/generic non-preferred prescriptions will reimburse at the NADAC brand cost basis when submitted using a DAW code of 1 or 8 (or 7 for NTI drugs). The use of DAW code 9 for brand preferred/generic non-preferred prescriptions will not allow these prescriptions to be correctly reimbursed and will result in an underpayment.

DMA is aware of concerns over the use of DAW codes 1 and 8 for brand preferred/generic non-preferred prescriptions and has identified a solution that will not require brand preferred/generic non-preferred prescriptions to be submitted with a DAW code in order for these prescriptions to be correctly reimbursed. This solution is currently being developed and tested by CSRA, the vendor responsible for maintaining NCTracks, and has been given a priority status. Further information will be provided once the solution is scheduled for implementation into NCTracks.

Until the final solution is implemented into NCTracks, pharmacy providers may submit their claims for brand preferred/generic non-preferred prescriptions using a DAW code 1 or 8 (or 7 for NTI drugs) as stated above. Pharmacy providers may also wait until the final solution is implemented into NCTracks when the use of a DAW code will not be required and resubmit their claims where underpayment has occurred at that time.